The antiviral remdesivir has shown promise for treating coronavirus, and the head of the drug’s maker, Gilead Sciences, said he’s committed to ensuring anyone who needs the drug will have access to it. ‘We’re going to work very closely with the government and with health care systems to make sure that it’s accessible, that it’s … Read more
President Donald Trump announced Friday that the FDA has approved the experimental drug remdesivir for emergency use in hospitalized coronavirus patients. It is the first drug shown to help fight the disease, which has killed more than 64,000 people in the United States. Gilead’s chief executive officer Daniel O’Day, whose company produces remdesivir joined President Trump, … Read more
Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings. ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more
On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News. ‘Positive data’ from … Read more
One of the doctors behind a promising remdesivir study, which shows it can be used as a treatment for COVID-19, has called it a ‘glimmer of hope’ and says he is now studying how to use the Ebola drug with other medications to give patients ‘tailored therapies’. His promising comments came on Thursday morning after … Read more
The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more
The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more
A trial of the antiviral drug remesivir has resulted ‘positive data’ for treating coronavirus patients, its maker, Gilead Sciences, said Wednesday. Gilead was expected this week to announce the results of a clinical trial testing the drug, which was originally developed to treat Ebola patients, in people severely ill with coronavirus. Half of the 397 … Read more
The first results from an international experimental US antiviral drug are promising, even as a trial of the same drug in China shuts down. More than half of a group of severely ill coronavirus patients from the US, Canada, Europe and Japan improved after taking remdesivir made by California-based Gilead Sciences. Originally developed as a … Read more
Washington Dulles International Airport has hired part-time staff screen travelers for the Ebola virus, an administrative coordinator at the Northern Virginia Emergency Medical Services Council (NVEMSC) told DailyMail.com. NVEMSC as well as several other groups made job postings for screeners earlier this year, and the NVEMSC coordinator says that all of its positions have been … Read more